Komori
StemCell Institute (7096) · RiskRestated

Risk of human error arising from manual work

First written in FY2021. 4 of 5 entries say "Restated". Latest entry: FY2026.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20262021: 120212022: 120222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Operational risk arising from human error and internal misconductA theme 74 companies write about · 75 as a headwind · 0 as a tailwind

45 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 73 companies compared. The sentences above are computed from all 73.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Our principal business, the cell banking business, involves substantial manual work in the transportation, separation and storage of cells. To prevent human error, we are actively adopting external certification systems, including ISO, AABB and the P Mark, and are working to establish an appropriate checking system. However, human error could affect our business or financial results.」

    The risk of human error arising from manual operations and the response through ISO, AABB, the P Mark and a checking system continue to be maintained.
  2. FY2025RestatedAnnual report

    「Our principal business, the cell banking business, involves substantial manual work in the transportation, separation and storage of cells. To prevent human error, we are actively adopting external certification systems, including ISO, AABB and the P Mark, and are working to establish an appropriate checking system.」

    The risk of human error arising from manual operations and the response through external certification and a checking system continue to be maintained.
  3. FY2023RestatedAnnual report

    「Because the transportation, separation and storage of cells involve substantial manual work, we are actively adopting external certification systems, including ISO, AABB and the P Mark, to prevent human error, and are working to establish an appropriate checking system.」

    The risk of human error arising from manual operations and the response through external certification and a checking system continue to be maintained.
  4. FY2022RestatedAnnual report

    「Because the transportation, separation and storage of cells involve substantial manual work, we are actively adopting external certification systems, including ISO, AABB and the P Mark, to prevent human error, and are working to establish an appropriate checking system.」

    The risk of human error arising from manual operations and the response through external certification and a checking system continue to be described.
  5. FY2021First statedAnnual report

    「Our principal business, the cell banking business, involves substantial manual work in the transportation, separation and storage of cells. To prevent human error, we are actively adopting external certification systems, including ISO, AABB and the P Mark, and are working to establish an appropriate checking system.」

    External certification systems and the establishment of a checking system are in place as countermeasures.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for StemCell Institute yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.